Lead monitoring frequency based on lead and patient characteristics

• US 9,399,141 B2
• Filed: 02/13/2014
• Issued: 07/26/2016
• Est. Priority Date: 02/13/2014
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Gunderson, Bruce D
• Primary Examiner(s): Lavert, Nicole F
• Application Number:
  US14/180,201
• Publication Number:
  US 20150224319A1
• Time in Patent Office: 894 Days
• Field of Search: 607/7, 607/62
• US Class Current: 1/1
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371

Abstract

A method and device for updating a frequency of determining whether a lead condition is occurring in a medical device that includes sensing a cardiac signal, determining the number of days the lead has been implanted prior to implanting of the medical device, performing a first update of a virtual lead days value associated with a number of days since implant of the lead in response to the determined number of days the lead has been implanted prior to implanting of the medical device, determining whether a lead condition is occurring in response to the sensed cardiac signal, and updating a frequency of determining whether the lead condition is occurring in response to the determined first update of the virtual lead days value.

Claims

1. An implantable medical device, comprising:

an implantable medical device housing containing electronic circuitry;

an implantable lead electrically coupled to the housing;

an electrode positioned along the lead to sense a cardiac signal and to deliver cardiac therapy; and

a processor positioned within the housing and configured to determine the number of days the lead has been implanted prior to implanting of the medical device, perform a first update of a virtual lead days value associated with a number of days since implant of the lead in response to the determined number of days the lead has been implanted prior to implanting of the medical device, determine whether a lead condition is occurring in response to the sensed cardiac signal, and update a frequency of determining whether the lead condition is occurring in response to the determined first update of the virtual lead days value, wherein the processor is configured to perform the first update by increasing the virtual lead days value by the determined number of days the lead has been implanted prior to implanting of the medical device.

2. The medical device of claim 1, wherein the processor is configured to determine a pre-implant patient characteristic occurring during the determined number of days the lead has been implanted prior to implanting of the medical device, perform a second update of the virtual lead days value in response to the determined pre-implant patient characteristic, and update the frequency of determining whether the lead condition is occurring in response to the first update of the virtual lead days value and the second update of the virtual lead days value.

3. The medical device of claim 2, wherein the pre-implant patient characteristic comprises a patient age and the processor is configured to increase the virtual lead days value in response to the patient age being within a predetermined patient age range and to not increase the virtual lead days value in response to the patient age being outside the predetermined patient age range.

4. The medical device of claim 2, wherein the pre-implant patient characteristic comprises a patient activity level and the processor is configured to increase the virtual lead days value in response to the patient activity level being greater than an activity level threshold.

5. The medical device of claim 2, wherein the pre-implant patient characteristic comprises a number of cardiac cycles and the processor is configured to increase the virtual lead days value in response to the number of cardiac cycles being greater than a number of cardiac cycles threshold.

6. The medical device of claim 2, wherein the pre-implant patient characteristic comprises at least one of a patient age, a patient activity level and a number of cardiac cycles, and the processor is configured to increase the virtual lead days value in response to the patient age being within a predetermined patient age range, increase the virtual lead days value in response to the patient activity level being greater than an activity level threshold, and increase the virtual lead days value in response to the number of cardiac cycles being greater than a number of cardiac cycles threshold.

7. The medical device of claim 1, wherein the processor is configured to determine a post implant patient characteristic occurring subsequent to implanting of the medical device, perform a second update of the virtual lead days value in response to the determined post-implant patient characteristic, and update the frequency of determining whether the lead condition is occurring in response to both the determined first update of the virtual lead days value and the determined second update of the virtual lead days value.

8. The medical device of claim 7, wherein the processor is configured to determine a pre-implant patient characteristic occurring during the determined number of days the lead has been implanted prior to implanting of the medical device, perform a third update of the virtual lead days value in response to the determined pre-implant patient characteristic, and update the frequency of determining whether the lead condition is occurring in response to the determined first update of the virtual lead days value, the determined second update of the virtual lead days value, and the determined third update of the virtual lead days value.

9. The medical device of claim 8, wherein both the pre-implant patient characteristic and the post-implant characteristic comprises at least one of a patient age, a patient activity level and a number of cardiac cycles, and the processor is configured to increase the virtual lead days value in response to the patient age being within a predetermined patient age range, increase the virtual lead days value in response to the patient activity level being greater than an activity level threshold, and increase the virtual lead days value in response to the number of cardiac cycles being greater than a number of cardiac cycles threshold.

10. A method of updating a frequency of determining whether a lead condition is occurring in a medical device electrically couple to a medical device a lead, comprising:

sensing a cardiac signal;

determining the number of days the lead has been implanted prior to implanting of the medical device;

performing a first update of a virtual lead days value associated with a number of days since implant of the lead in response to the determined number of days the lead has been implanted prior to implanting of the medical device;

determining whether a lead condition is occurring in response to the sensed cardiac signal;

and updating a frequency of determining whether the lead condition is occurring in response to the determined first update of the virtual lead days value, wherein performing the first update comprises increasing the virtual lead days value by the determined number of days the lead has been implanted prior to implanting of the medical device.

11. The method of claim 10, further comprising:

determining a pre-implant patient characteristic occurring during the determined number of days the lead has been implanted prior to implanting of the medical device;

performing a second update of the virtual lead days value in response to the determined pre-implant patient characteristic; and

updating the frequency of determining whether the lead condition is occurring in response to the first update of the virtual lead days value and the second update of the virtual lead days value.

12. The method of claim 11, wherein the pre-implant patient characteristic comprises a patient age and further comprising:

increasing the virtual lead days value in response to the patient age being within a predetermined patient age range; and

not increasing the virtual lead days value in response to the patient age being outside the predetermined patient age range.

13. The method of claim 11, wherein the pre-implant patient characteristic comprises a patient activity level and further comprising increasing the virtual lead days value in response to the patient activity level being greater than an activity level threshold.

14. The method of claim 11, wherein the pre-implant patient characteristic comprises a number of cardiac cycles and further comprising increasing the virtual lead days value in response to the number of cardiac cycles being greater than a number of cardiac cycles threshold.

15. The method of claim 11, wherein the pre-implant patient characteristic comprises at least one of a patient age, a patient activity level and a number of cardiac cycles, and further comprising:

increasing the virtual lead days value in response to the patient age being within a predetermined patient age range;

increasing the virtual lead days value in response to the patient activity level being greater than an activity level threshold; and

increasing the virtual lead days value in response to the number of cardiac cycles being greater than a number of cardiac cycles threshold.

16. The method of claim 10, further comprising:

determining a post implant patient characteristic occurring subsequent to implanting of the medical device;

performing a second update of the virtual lead days value in response to the determined post-implant patient characteristic; and

updating the frequency of determining whether the lead condition is occurring in response to both the determined first update of the virtual lead days value and the determined second update of the virtual lead days value.

17. The method of claim 16, further comprising:

determining a pre-implant patient characteristic occurring during the determined number of days the lead has been implanted prior to implanting of the medical device;

performing a third update of the virtual lead days value in response to the determined pre-implant patient characteristic; and

updating the frequency of determining whether the lead condition is occurring in response to the determined first update of the virtual lead days value, the determined second update of the virtual lead days value, and the determined third update of the virtual lead days value.

18. The method of claim 17, wherein both the pre-implant patient characteristic and the post-implant characteristic comprises at least one of a patient age, a patient activity level and a number of cardiac cycles, and further comprising:

increasing the virtual lead days value in response to the patient age being within a predetermined patient age range;

increase the virtual lead days value in response to the patient activity level being greater than an activity level threshold; and

increasing the virtual lead days value in response to the number of cardiac cycles being greater than a number of cardiac cycles threshold.

19. A non-transitory computer readable medium storing a set of instructions which when implemented in a medical device cause the device to perform a method for updating a frequency of determining whether a lead condition is occurring, the method comprising:

sensing a cardiac signal;

determining the number of days the lead has been implanted prior to implanting of the medical device;

performing a first update of a virtual lead days value associated with a number of days since implant of the lead in response to the determined number of days the lead has been implanted prior to implanting of the medical device;

determining whether a lead condition is occurring in response to the sensed cardiac signal;

and updating a frequency of determining whether the lead condition is occurring in response to the determined first update of the virtual lead days value, wherein performing the first update comprises increasing the virtual lead days value by the determined number of days the lead has been implanted prior to implanting of the medical device.